Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7658 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2022-05-05	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HB7658

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HB7658 currently on file.

Social Comments on US HB7658